INNOVAR Corp. The company is headquartered in New York, New York.
| Revenue (TTM) | $1.52B |
| Gross Profit (TTM) | $241.60M |
| EBITDA | $94.40M |
| Operating Margin | 8.18% |
| Return on Equity | -19.10% |
| Return on Assets | 4.28% |
| Revenue/Share (TTM) | $113.72 |
| Book Value | $-17.83 |
| Price-to-Book | 0.74 |
| Price-to-Sales (TTM) | 0.06 |
| EV/Revenue | 0.461 |
| EV/EBITDA | 6.12 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 74.20% |
| Shares Outstanding | $13.64M |
| Float | $3.35M |
| % Insiders | 62.47% |
| % Institutions | 23.20% |
Volatility is currently contracting
VATE completes the DBM Global sale for about $413 million in cash plus IES shares, with net proceeds earmarked to reduce debt and boost flexibility.
NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- INNOVATE CORP.® (NYSE: VATE) (“INNOVATE”) announced today that it has completed the previously announced sale of DBM Global, Inc. (“DBMG”) to IES Holdings, Inc. (Nasdaq: IESC) (“IES”) pursuant to the Transaction Agreement (the “Agreement”) announced on August 10, 2026 (the “Transaction”).
NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- INNOVATE CORP.
INNOVATE swings to a Q2 profit as revenues surge 74.2% y/y, fueled by DBM Global's growth, wider margins and backlog gains, while debt and liquidity remain in focus.
NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- INNOVATE CORP.® (NYSE: VATE) (“INNOVATE”) announced today that MediBeacon Inc. (“MediBeacon”), a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, and an equity method investment of INNOVATE, announced that The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, has nominated the MediBeacon® TGFR™ System for the 2026 Prix Galien USA Best Medical Technology.
INNOVATE Corp. (VATE) Q2 2026 Earnings Call Prepared Remarks Transcript
NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- INNOVATE CORP.® (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the second quarter 2026 on Thursday, August 6, 2026, after market close.
NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- INNOVATE CORP.® (NYSE:VATE) (“INNOVATE” or the “Company”) announced today that DBM Global Inc. (“DBMG”), a family of companies providing fully integrated steel construction services, and an operating subsidiary of INNOVATE, will pay a cash dividend of approximately $12 million, or $3.12 per share, on August 3, 2026 to DBMG's stockholders of record at the close of business on July 20, 2026. As the largest stockholder of DBMG, INNOVATE expects to receive approximately $11 million of the total $12 million dividend payout. INNOVATE's individual stockholders are not eligible to receive the cash dividend.
NEW YORK, June 01, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that HC2 Broadcasting Holdings Inc. (“Broadcasting”) closed on a refinancing transaction and that Broadcasting and HC2 Broadcasting Holdco, LLC (“HC2 Holdco”), subsidiaries of INNOVATE, have entered into a definitive agreement pursuant to which INNOVATE will sell a controlling interest in Broadcasting to CONX CORP. (“CONX”), subject to the satisfaction of customary closing conditions, including the receipt of required regulatory approvals. After the closing of the transaction, it is expected that CONX will own approximately 75% of Broadcasting and INNOVATE will own approximately 25% of Broadcasting through HC2 Holdco.
VATE's Q1 revenues jump 33% as AI-driven infrastructure demand boosts DBM Global, offsetting weakness in Spectrum and Life Sciences.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on VATE and any ticker you trade — then tracks every position and per-strategy win rate.
